STAT+: Pharmalittle: We’re reading about a Supreme Court setback for pharma, TrumpRx expands and much more

The US Supreme Court declined to hear lawsuits from brand-name pharmaceutical companies against the Medicare drug price negotiation program, and the TrumpRx prescription drug discount platform is expanding with over 600 generic drugs. The expansion is a result of partnerships with Mark Cuban's Cost Plus Drug Company, Amazon Pharmacy, and GoodRx. This development may make remaining legal challenges more difficult for the drug industry.